Gossamer Bio GOSS
NASDAQ GOSS
$0.15 0.00 (-1.78%)
At close: Aug 21, 2026 · 4:00 PM EDT

Gossamer Bio (GOSS) Receivables - Net (2024 - 2026)

Gossamer Bio (GOSS) posted quarterly Receivables - Net of $9.3 million for Q1 2026, up 40.54% year-over-year from $6.6 million in Q1 2025, and down 24.33% quarter-over-quarter from $12.2 million in Q4 2025.

Gossamer Bio (GOSS) Receivables - Net (2024 - 2026) Analysis & Trends

Gossamer Bio's Receivables - Net history runs 3 years deep, the most recent figure standing at $9.3 million for Q1 2026.

  • In Q1 2026, Receivables - Net rose 40.54% year-over-year to $9.3 million; the TTM figure through Mar 2026 stood at $9.3 million (up 40.54% YoY), while the FY2025 annual figure was $12.2 million, up 129.06% from the prior year.
  • Receivables - Net for Q1 2026 stood at $9.3 million, down from $12.2 million in the prior quarter.
  • The five-year high for Receivables - Net was $12.2 million in Q4 2025, with the low at $3.6 million in Q2 2024.
  • The 3-year median for Receivables - Net is $7.1 million (2024), against an average of $7.6 million.
  • Peak annual rise in Receivables - Net reached 129.06% in 2025, while the deepest fall reached 40.3% in 2025.
  • Gossamer Bio's Receivables - Net stood at $5.3 million in 2024, then surged by 129.06% to $12.2 million in 2025, then dropped by 24.33% to $9.3 million in 2026.
  • Business Quant data shows GOSS's Receivables - Net at $9.3 million in Q1 2026, $12.2 million in Q4 2025, and $9.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Gossamer Bio 49.15 Mn -7.87 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 6.11 Mn
Jun 30, 2026 6.11 Mn
Mar 31, 2026 9.25 Mn
Mar 31, 2026 9.25 Mn
Dec 31, 2025 12.23 Mn
Dec 31, 2025 12.23 Mn
Sep 30, 2025 9.24 Mn
Sep 30, 2025 9.24 Mn
Jun 30, 2025 7.58 Mn
Jun 30, 2025 7.58 Mn
Mar 31, 2025 6.58 Mn
Mar 31, 2025 6.58 Mn
Dec 31, 2024 5.34 Mn
Dec 31, 2024 5.34 Mn
Sep 30, 2024 6.59 Mn
Sep 30, 2024 6.59 Mn
Jun 30, 2024 3.63 Mn
Jun 30, 2024 3.63 Mn